Oncology Japan 2012

Deliver the most appropriate cancer treatments for patients and maximize your sales revenue

Oncology Japan is the one and only event to focus on innovative R&D, sales and marketing strategies in the Japanese Oncology market and beyond, and in its 3rd edition it will provide you the ultimate knowledge and networking experiences. With over 250 senior-level attendees, this is by far the biggest, best and most influential Pharma Oncology event.

News：

Main topics:

• Understand the trends and issues of personalized medicine and predict how the oncology market is going to look in the future: Co-development of molecular target drugs and cpmpanion diagnostics. Current issues of drugs approval and health insurance reimbursement
• Optimum marketing strategies in order to raise awareness of chemotherapy among physicians, paramedic and patients: How to deliver right information to healthcare providers and patients
• Assess the most effective commercial strategies maximize your revenue in oncology market: Improve commercial feasibility and value of your products with portfolio management that meets market needs
• How to raise your sales force standard to transform your MR into a treatment partner: Support regional medical liaison and multidisciplinary healthcare approaches with your sales force
• What pharma can do to deliver better cancer treatments for patients: Hear the case studies regarding AE Management, supportive care and palliative care from healthcare providers

An informative overview of current thinking about succeeding in the Japanese Oncology market

20+ experts to present, discuss, and provide solutions

A snapshot of expert speakers

• Kazuo Asakawa, Director Head Oncology Division, Novartis Pharma K.K.
• Jun Katsura, Global Marketing Director, Global Marketing and Sales Operations, AstraZeneca, PLC
• Makoto Nakamura, Oncology Business Unit Head, Pfizer Japan Inc.
• Shinichi Nihira, Head of Medical Affairs Division, Chugai Pharmaceutical Co., Ltd.

• Shinichi Nishiuma, Lead Physician, Global Patient Safety Japan- Medical, Surveillance & Epidemiology, Eli Lilly Japan K.K.

• Tsutomu Nobori, Dean, Graduate School of Medicine, Mie University
• Takahisa Yamazaki, Oncology Marketing Dept. Oncology, Virology & Immunology Business Unit,
  Janssen Pharmaceutical K.K.
• Kenichi Hanioka, Board member, Cancer Information Center, Commission on Citizens and Health,
  Health and Global Policy Institute

Download NowCheck out the full conference brochure here

Experts in Oncology are ready to share their knowledge with you

Not only key players in Oncology will attend the Oncology Japan 2012, but also we have the very best speakers in the market poised ready to discuss key challenges and opportunities.

Key Features:

• PRESENTATIONS from key players within Pharmaceutical industries
• PANEL DISCUSSIONS covering a variety of topics of interest to stakeholders, including medical professionals (cancer specialist nurse / pharmacist / Oncologist), governmental body and patient groups
• Timely CASE STUDIES of sales and marketing strategies within Oncology
• Numerous NETWORKING OPPORTUNITIES

Key Networking Opportunities:

• Develop key relationships with thought leaders in Oncology
• Hear fresh and innovative solutions to push your oncology strategy forward
• Gain insights from them most dynamic figures that work in Oncology

Well organised. Good job Eye for Pharma - you have come a long way in just a couple of years

CONTACT US:

If you are interested in participating, please contact us:

For conference program, attending and speaking opportunities:

Akimitsu Takata Email: akimitsu@eyeforpharma.com

For exhibition and sponsorship:

Kunie Akahoshi Email: kakahoshi@eyeforpharma.com